SyntekaBio

226330 · KOSDAQ · Information Technology · SMALL CAP

A major new order.

SyntekaBio disclosed a supply contract with AtoResearch Co., Ltd., worth US$4.3M, about 188.96% of its recent annual revenue, running through Oct 2029.

Supply contract(Supply contract signed)· FILED 2026-07-09· RCEPT 20260709900489

US$4.3MContract value
188.96%vs. recent revenue
Oct 2029Throughfrom Nov 2026

Converted at 1 USD ≈ ₩1,505.91 (filing-date rate, 2026-07-09 close)

What happened

SyntekaBio disclosed a supply contract with AtoResearch Co., Ltd., worth US$4.3M, about 188.96% of its recent annual revenue, running through Oct 2029.

For context, this single contract equals about 188.96% of the company's most recent annual revenue.

CounterpartyAtoResearch Co., Ltd.
Contract valueUS$4.3M
vs. recent revenue188.96%
ThroughOct 2029 (from Nov 2026)
Filed2026-07-09, Supply contract signed
SourceDART rcept 20260709900489 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-09 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.